FDA Needs Smart Folks for Food and Drug Advice Committees
Published Date: 10/1/2026
Notice
Summary
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Open Opportunity to Join FDA Advisory Panels
You can apply to serve as a voting member on FDA standing advisory committees any time because nominations are accepted on a continuing basis. If you submit a nomination on or before November 30, 2026, it will get first consideration for current and near-term vacancies.
Who May Apply and Required Documents
Only U.S. Citizens, non-citizen U.S. Nationals, and Permanent Residents may apply to be voting members. Nominations must include a current, complete résumé or curriculum vitae, must specify which advisory committee the nominee is recommended for, and must acknowledge that the nominee is aware of the nomination; self-nominations are accepted.
Appointment Status, Ethics, and Disclosure Rules
If you are a non-Federal voting member you will generally be appointed as a special Government employee and must follow Federal ethics and conflict-of-interest rules. FDA will ask potential appointees to provide detailed information about financial holdings, employment, and research grants or contracts to evaluate possible conflicts of interest.
Patients and Sponsors May Recommend for Device Panels
For medical device classification panels, patients, representatives of patients, and sponsors of medical devices may recommend individuals with appropriate expertise for voting-member positions, under section 513(b)(5)(D) of the Federal Food, Drug, and Cosmetic Act.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20085, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Improvement Program
The FDA is asking for public feedback by November 2, 2026, on its Voluntary Improvement Program (VIP), which helps medical device makers improve quality through third-party reviews. This program supports better products and safer devices without adding extra costs or deadlines for companies. It’s all about encouraging excellence and teamwork between the FDA, industry, and partners like the Medical Device Innovation Consortium.
2026-19968, Determination That ISTURISA (Osilodrostat) Tablets, 10 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that ISTURISA (osilodrostat) 10 mg tablets were not taken off the market because of safety or effectiveness problems. This means generic drug makers can now apply to sell their own versions of ISTURISA, as long as they meet all the rules. Patients and pharmacies could see more affordable options soon, with no safety worries involved.
Previous / Next Documents
Previous: 2026-20061, Superfund Tax on Chemical Substances; Request To Modify List of Taxable Substances; Notice of Filing for Styrene Isoprene Block Copolymer; x+z=482, y=2,178.51, a=1.70
The IRS got a request to add a new chemical called SIS Rubber to the list of substances that get a Superfund tax. This means companies making or using SIS Rubber might pay extra fees if it’s added. People have until November 30, 2026, to share their thoughts or ask for a public hearing before any decision is made.
Next: 2026-20065, Request for Nominations for Individuals and Consumer Organizations for Advisory Committees
The FDA is looking for people and consumer groups to join its advisory committees and share their views on important health topics. If you or your group want to help pick voting or nonvoting members, or if you want to be nominated yourself, act by November 16, 2026. This is a great chance to have a say in decisions that affect everyone’s health, with no cost to apply!